EVH:NYE-Evolent Health Inc Class A (USD)

EQUITY | Health Information Services | New York Stock Exchange

Last Closing

USD 32.73

Change

+0.60 (+1.87)%

Market Cap

USD 1.38B

Volume

0.59M

Analyst Target

USD 11.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Evolent Health Inc is engaged in healthcare delivery and payment. It markets and sells its services to providers throughout the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
VEEV Veeva Systems Inc Class A

+1.82 (+0.91%)

USD 32.00B
SOLV Solventum Corp.

+2.60 (+4.21%)

USD 11.73B
DOCS Doximity Inc

+0.23 (+0.97%)

USD 4.83B
TDOC Teladoc Inc

-0.32 (-2.40%)

USD 2.20B
AGTI Agiliti Inc

+0.01 (+0.10%)

USD 1.37B
PHR Phreesia Inc

+0.15 (+0.73%)

USD 1.30B
SLP Simulations Plus Inc

-0.96 (-2.10%)

USD 0.88B
MPLN MultiPlan Corporation

N/A

USD 0.43B
AMWL American Well Corp

-0.01 (-2.13%)

USD 0.16B
OWLT Owlet Inc

+0.18 (+4.52%)

USD 0.03B

ETFs Containing EVH

EDOC:AU BetaShares Digital Health.. 4.13 % 0.00 %

-0.04 (-0.45%)

N/A
ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

+0.33 (+-0.45%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.91% 55% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.91% 55% F 23% F
Trailing 12 Months  
Capital Gain 5.85% 91% A- 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.85% 91% A- 34% F
Trailing 5 Years  
Capital Gain 160.17% 100% F 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 160.17% 100% F 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 50.18% 91% A- 95% A
Dividend Return 50.18% 91% A- 95% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 72.62% 36% F 11% F
Risk Adjusted Return 69.10% 100% F 92% A
Market Capitalization 1.38B 82% B 73% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 643.99 13% 1%
Price/Book Ratio 3.48 55% 25%
Price / Cash Flow Ratio 26.08 27% 11%
Price/Free Cash Flow Ratio -168.27 100% 99%
Management Effectiveness  
Return on Equity -10.74% 45% 17%
Return on Invested Capital 1.24% 45% 28%
Return on Assets 0.86% 55% 30%
Debt to Equity Ratio 55.92% 71% 58%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.